» Articles » PMID: 23597659

Technologies for Deriving Primary Tumor Cells for Use in Personalized Cancer Therapy

Overview
Specialty Biochemistry
Date 2013 Apr 20
PMID 23597659
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

For decades, immortal cancer cell lines have constituted an accessible, easily usable set of biological models to investigate cancer biology and explore the potential efficacy of anticancer drugs. However, numerous studies have suggested that these cell lines poorly represent the diversity, heterogeneity, and drug-resistant tumors occurring in patients. The derivation and short-term culture of primary cells from solid tumors have thus gained significant importance in personalized cancer therapy. This review focuses on our current understanding and the pros and cons of different methods for primary tumor cell culture. Furthermore, various culture matrices such as biomimetic scaffolds and chemically defined media supplemented with essential nutrients, have been prepared for different tissues. These well-characterized primary tumor cells redefine cancer therapies with high translational relevance.

Citing Articles

Evaluation of Spliceosome Protein SmD2 as a Potential Target for Cancer Therapy.

Li J, Li P, Brachtlova T, van der Meulen-Muileman I, Dekker H, Kumar V Int J Mol Sci. 2024; 25(23).

PMID: 39684842 PMC: 11642717. DOI: 10.3390/ijms252313131.


Unite and Conquer: Association of Two G-Quadruplex Aptamers Provides Antiproliferative and Antimigration Activity for Cells from High-Grade Glioma Patients.

Pavlova S, Fab L, Dzarieva F, Ryabova A, Revishchin A, Panteleev D Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598347 PMC: 11597096. DOI: 10.3390/ph17111435.


Feasibility and barriers to rapid establishment of patient-derived primary osteosarcoma cell lines in clinical management.

Chow T, Humble W, Lucarelli E, Onofrillo C, Choong P, Di Bella C iScience. 2024; 27(9):110251.

PMID: 39286504 PMC: 11403063. DOI: 10.1016/j.isci.2024.110251.


Chitosan Nanoparticle-Mediated Delivery of Curcumin Suppresses Tumor Growth in Breast Cancer.

Mishra B, Yadav A, Malhotra D, Mitra T, Sinsinwar S, Radharani N Nanomaterials (Basel). 2024; 14(15).

PMID: 39120399 PMC: 11314098. DOI: 10.3390/nano14151294.


Comparison of primary and passaged tumor cell cultures and their application in personalized medicine.

Pipiya V, Gilazieva Z, Issa S, Rizvanov A, Solovyeva V Explor Target Antitumor Ther. 2024; 5(3):581-599.

PMID: 38966179 PMC: 11220317. DOI: 10.37349/etat.2024.00237.


References
1.
Parajuli N, Doppler W . Precision-cut slice cultures of tumors from MMTV-neu mice for the study of the ex vivo response to cytokines and cytotoxic drugs. In Vitro Cell Dev Biol Anim. 2009; 45(8):442-50. DOI: 10.1007/s11626-009-9212-7. View

2.
Battula V, Shi Y, Evans K, Wang R, Spaeth E, Jacamo R . Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis. J Clin Invest. 2012; 122(6):2066-78. PMC: 3591166. DOI: 10.1172/JCI59735. View

3.
Trusheim M, Burgess B, Hu S, Long T, Averbuch S, Flynn A . Quantifying factors for the success of stratified medicine. Nat Rev Drug Discov. 2011; 10(11):817-33. DOI: 10.1038/nrd3557. View

4.
Singh S, Clarke I, Terasaki M, Bonn V, Hawkins C, Squire J . Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63(18):5821-8. View

5.
McCallum H, Lowther G . Long-term culture of primary breast cancer in defined medium. Breast Cancer Res Treat. 1996; 39(3):247-59. DOI: 10.1007/BF01806153. View